Mirum Pharmaceuticals

MIRM65

High Growth

$46.42arrow_drop_down0.42%-$0.19

High Growth

MIRM65

$46.42

arrow_drop_down0.42%-$0.19

High Growth

Performance History

Key Stats
Open	$46.56
Prev. Close	$46.65
EPS	-2.08
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	46.08	48.33
52 Week Range	23.14	48.84

Ratios







EPS	-2.08

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Mirum Pharmaceuticals (MIRM)

Mirum Pharmaceuticals Inc (MIRM) is a biopharmaceutical company that focuses on the development and commercialization of therapies for patients with rare liver diseases. The company's mission is to bring innovative treatments to patients in need. With a strong dedication to research and development, Mirum is committed to advancing science and improving the lives of individuals affected by rare liver diseases.

MIRM's stock price history reflects the company's growth and potential. The stock has shown positive momentum over the years, with a steady increase in value. Investors have been drawn to MIRM's innovative pipeline and promising clinical trial results. As a result, the stock price has experienced upward trends, reflecting market confidence in the company's ability to deliver on its mission.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Christopher Peetz
Headquarters: Foster City
Employees: 213
Exchange: NASDAQ

Keep an eye on Mirum Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Mirum Pharmaceuticals 's (MIRM) price per share?

The current price per share for Mirum Pharmaceuticals (MIRM) is $46.42. The stock has seen a price change of -$0.2 recently, indicating a -0.43% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Mirum Pharmaceuticals (MIRM)?

For Mirum Pharmaceuticals (MIRM), the 52-week high is $48.84, which is 5.21% from the current price. The 52-week low is $23.14, the current price is 100.61% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Mirum Pharmaceuticals (MIRM) a growth stock?

Mirum Pharmaceuticals (MIRM) has shown an average price growth of -2.94% over the past three years. It has received a score of 87 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Mirum Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Mirum Pharmaceuticals (MIRM) stock price performance year to date (YTD)?

As of the latest data, Mirum Pharmaceuticals (MIRM) has a year-to-date price change of 54.63%. Over the past month, the stock has experienced a price change of 17.4%. Over the last three months, the change has been 5.81%. Over the past six months, the figure is 87.48%. Looking at a longer horizon, the five-year price change stands at 543.83%.

help

Is Mirum Pharmaceuticals (MIRM) a profitable company?

Mirum Pharmaceuticals (MIRM) has a net income of -$163.42M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 74.76% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -14.04% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $186.37M, although specific revenue growth data is currently not available. The gross profit is $139.34M. Operating income is noted at -$109.15M. Furthermore, the EBITDA is -$72.9M.

help

What is the market capitalization of Mirum Pharmaceuticals (MIRM)?

Mirum Pharmaceuticals (MIRM) has a market capitalization of $2.22B. The average daily trading volume is 46.61, indicating the stock's liquidity and investor engagement.